Oncology & Hematology Coding Alert
Follow-up Care is Key to Xofigo Coding
Question: In a patient with advanced resistant prostate cancer, our oncologist administered radium Ra 223 (Xofigo). How can we report for this service? How do we code for the planned injections of Xofigo?
North Carolina Subscriber
Answer: Radium Ra 223 (Xofigo) is administered as a regimen of 6 injections. Your physician may plan for a total of 6 injections to be administered at 4 week intervals. The dose of radium Ra 223 is 50 kBq (1.35 microcurie) per kg body weight.
Two options: You have two options to report the administration of the radiopharmaceutical Xofigo:
How to choose: When your provider is certain about seeing the patient for follow-up care, you submit code 79101. However, when your provider does not anticipate to see the patient again as part of regular follow-up, you submit code 77750. The code 77750 applies to any unplanned follow-up care that your physician provides in the 90-day global period.
Oncology & Hematology Coding Alert
- Coding Strategy:
Doctor Prescribing Venetoclax for CLL Patients? Here's What to Submit
Keep documentation for patient selection and any prior treatment. Have you been coding accurately for [...] - News You Can Use:
ASTRO Makes Clear Recommendations For Justified RVUs In 2017
Arbitrary crosswalks may mislead; RUC recommendations should be considered. Are you curious how your relative [...] - CMS Announced End To Flexibilities Beyond Oct. 1, 2016
Practices have no option but to adopt specificity and accuracy. ICD-10-CM codes apply to your [...] - ICD-10-CM Update:
Look Beyond Cancer Diagnosis Codes To Capture All Complaints
Fatigue and malaise may not be clearly differentiated but they have separate codes. Watch out [...] - You Be the Coder:
Confirm Chemotherapy in High-Risk Medication
Question: Our physician is treating a pregnant woman with chemotherapy. This is clearly use of a [...] - Reader Question:
Split Services Mandate Same Patient and Same Date
Question: Is a common date of service mandatory for split visits? Do visits in outpatient and [...] - Reader Question:
Never Ignore Carrier State Confirmation
Question: Our physician has documented a family history of thalassemia carrier state. Do we need to [...] - Reader Question:
Follow-up Care is Key to Xofigo Coding
Question: In a patient with advanced resistant prostate cancer, our oncologist administered radium Ra 223 (Xofigo). [...] - Reader Question:
Counselling Time Determines E/M Coding
Question: How can we effectively report for counselling services of our provider? Is counselling a part [...]
